Development and characterization of SARS-CoV-2 variant-neutralizing monoclonal antibodies. Qiu H, Yuan XY, Cabral T, Manguiat K, et al. Antiviral Res 2021 Nov 8:105206. doi: 10.1016/j.antiviral.2021.105206.

Read + Share

Amedeo Smart

Independent Medical Education

Qiu H, Yuan XY, Cabral T, Manguiat K, et al. Development and characterization of SARS-CoV-2 variant-neutralizing monoclonal antibodies. Antiviral Res 2021 Nov 8:105206. doi: 10.1016/j.antiviral.2021.105206.
PMID: 34762975